Yungshin Global Holding Corp operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yungshin Global Holding Corp with three other
companies in this sector in Taiwan:
Lotus Pharmaceutical Co.,Ltd.
sales of 5.90 billion Taiwanese Dollars [US$195.49 million]
of which 94%
was Western Medicine Manufacture),
China Chemical and Pharmaceutical Company Limited
(5.78 billion Taiwanese Dollars [US$191.48 million]
of which 74%
was Taiwan), and
Pharmally International Holding Company Ltd
(4.33 billion Taiwanese Dollars [US$143.56 million]
Yungshin Global Holding Corp reported sales of 6.19 billion Taiwanese Dollars (US$205.04 million)
December of 2016.
increase of 2.6%
versus 2015, when the company's sales were 6.03 billion Taiwanese Dollars.
Sales at Yungshin Global Holding Corp have increased during each of the previous five years
(and since 2011, sales have increased a total of 38%).
Sales of Japanese District saw an increase
that was more than double the company's growth rate: sales were up
27.9% in 2016, from
565.99 million Taiwanese Dollars to 723.71 million Taiwanese Dollars.
Yungshin Global Holding Corp also saw significant increases in sales in
Taiwan District (up 9.1% to 4.58 billion Taiwanese Dollars)
Not all segments of Yungshin Global Holding Corp experienced an increase in sales in 2016:
sales of American District fell 51.1% to 295.09 million Taiwanese Dollars.
Yungshin Global Holding Corp also experienced decreases in sales in
China Mainland District (down 11.4% to 592.43 million Taiwanese Dollars)